Private NABL-accredited labs will soon be allowed to conduct coronavirus tests: ICMR

Image
Press Trust of India New Delhi
Last Updated : Mar 17 2020 | 9:06 PM IST

The Indian Council of Medical Research (ICMR) on Tuesday said private NABL-accredited laboratories will soon be allowed to conduct tests for COVID-19 to enhance capacity for diagnosis and detection amid rising novel coronavirus cases in the country.

ICMR Director General Balram Bhargava said the apex health research body of India has activated more laboratories to test for COVID-19 and revised the testing criteria.

"ICMR has been approached by several private players who want to contribute and talks are on with 51 National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited private laboratories to understand the modalities of increasing access to the test in the endeavour to prepare for future," he said.

He also appealed to all private laboratories to offer COVID-19 diagnosis free of cost.

The ICMR has equipped 72 of its laboratories to test for the pandemic disease. In addition to these labs, 49 more under organisations like Council of Scientific & Industrial Research, Department of Biotechnology, and Defence Research, Development Organisation would be equipped to test for coronavirus by end of this week, Bhargava said.

The ICMR will also be setting up two testing locations (NCR and Bhubaneswar) for high throughput diagnostic systems for exponentially increasing rapid diagnosing of the respiratory ailment.

These systems can test up to 1400 samples daily, he said.

The ICMR has also revised the testing criteria for COVID-19 under which an individual who had come in direct close physical contact of laboratory confirmed positive case, has a history of travel in last 14 days to high risk COVID-19 affected countries and develops symptoms like fever, cough and difficulty in breathing should immediately contact the health ministry's helpline for testing.

"In addition to these conditions, if a healthcare worker managing respiratory distress/severe acute respiratory illness shows symptoms of acute respiratory illness they should get a laboratory test for COVID-19.

"If these cases are tested positive, then they should be isolated and treated as per the standard protocols," Bhargava said.

"We at ICMR are regularly monitoring for community transmissions. Our labs are looking at random samples of patients who suffer from influenza like illnesses/ severe acute," he said, adding so far 500 samples have been tested and they have come out negative.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 17 2020 | 9:06 PM IST

Next Story